Federated Hermes, Inc. Acquires Significant Stake in Minerva Neurosciences, Inc.

Federated Hermes, Inc. (FHI) has filed a Schedule 13D with the SEC, disclosing its acquisition of a significant stake in Minerva Neurosciences, Inc. As of October 21, 2025, FHI holds 1,351,275 shares of Minerva's common stock, representing a 19.32% ownership stake. The shares were acquired for an aggregate purchase price of $62,384,163.53. FHI, through its subsidiaries, provides investment management services and acquired the shares for investment purposes in the ordinary course of business. The filing also includes details of a private placement where Minerva issued Series A Convertible Preferred Stock and warrants to certain investors, including FHI. The filing is jointly made by FHI, the Voting Shares Irrevocable Trust, and the trustees of the trust, who collectively exercise voting control over FHI. The filing emphasizes that it should not be construed as an admission of beneficial ownership of the securities by the reporting persons.